Evaluation of long-term safety and efficacy of omalizumab in elderly patients with uncontrolled allergic asthma

dc.contributor.authorTAT TUĞBA SONGÜL
dc.contributor.authorÇİLLİ AYKUT
dc.contributor.authorTat, Tuğba Songül
dc.date.accessioned2026-06-12T11:53:35Z
dc.date.issued2016
dc.descriptionSCI | YÖK-Özgeçmiş
dc.identifier.doi10.1016/j.anai.2016.09.006
dc.identifier.issn10811206
dc.identifier.urihttps://hdl.handle.net/20.500.11782/7358
dc.relation.ispartofAnnals of Allergy, Asthma Immunology
dc.titleEvaluation of long-term safety and efficacy of omalizumab in elderly patients with uncontrolled allergic asthma
dspace.entity.typePublication
relation.isAuthorOfPublication941f67ee-efde-472b-807c-c8238037af46
relation.isAuthorOfPublication.latestForDiscovery941f67ee-efde-472b-807c-c8238037af46

Dosyalar